持田製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4534/E00947 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2013/01/25 | 日証協 | 503,998株 | -3.06% | 133,965株 | -24.31% | 579,537株 | -3.68% | 73,865株 | +71.78% |
2013/01/18 | 日証協 | 519,933株 | +10.17% | 177,000株 | +60.91% | 601,672株 | +5.06% | 43,000株 | -56.17% |
2013/01/11 | 日証協 | 471,933株 | -2.66% | 110,000株 | +423.81% | 572,672株 | -1.53% | 98,101株 | 0% |
2013/01/04 | 日証協 | 484,833株 | +0.21% | 21,000株 | -88.84% | 581,571株 | 0% | 0株 | -100% |
2012/12/28 | 日証協 | 483,833株 | +9.26% | 188,100株 | -31.77% | 581,571株 | +5.8% | 42,000株 | -66.61% |
2012/12/21 | 日証協 | 442,833株 | +2.79% | 275,700株 | +20.83% | 549,672株 | 0% | 125,800株 | +39.21% |
2012/12/14 | 日証協 | 430,833株 | +13.13% | 228,165株 | -34.96% | 549,672株 | +7.64% | 90,365株 | +197.59% |
2012/12/07 | 日証協 | 380,837株 | -1.85% | 350,795株 | +9.14% | 510,676株 | -4.06% | 30,366株 | -47.97% |
2012/11/30 | 日証協 | 388,029株 | +7.97% | 321,430株 | +71.41% | 532,310株 | +8.46% | 58,365株 | +14.67% |
2012/11/22 | 日証協 | 359,394株 | -15.95% | 187,519株 | +368.8% | 490,775株 | -13.58% | 50,900株 | -56.09% |
2012/11/16 | 日証協 | 427,583株 | +5.68% | 40,000株 | -91.68% | 567,864株 | +4.22% | 115,908株 | -21.96% |
2012/11/09 | 日証協 | 404,583株 | +1.08% | 480,821株 | +79.56% | 544,864株 | +7.78% | 148,523株 | -39.91% |
2012/11/02 | 日証協 | 400,253株 | +13.91% | 267,771株 | +212.55% | 505,534株 | +6.53% | 247,167株 | +23.89% |
2012/10/26 | 日証協 | 351,379株 | -8% | 85,672株 | -23.53% | 474,560株 | -13.74% | 199,506株 | +18.19% |
2012/10/19 | 日証協 | 381,946株 | +1.6% | 112,033株 | +76.04% | 550,160株 | -1.79% | 168,794株 | +96.16% |
2012/10/12 | 日証協 | 375,946株 | -14.35% | 63,639株 | -71.41% | 560,160株 | -9.97% | 86,047株 | -58.03% |
2012/10/05 | 日証協 | 438,946株 | +7.49% | 222,600株 | +16.54% | 622,160株 | +15.61% | 205,000株 | -28.75% |
2012/09/28 | 日証協 | 408,346株 | +38.12% | 191,000株 | +607.41% | 538,149株 | +23.81% | 287,725株 | +3.04% |
2012/09/21 | 日証協 | 295,639株 | +13.59% | 27,000株 | -73.21% | 434,647株 | +23.21% | 279,235株 | +191.97% |
※株式分割は考慮していませんのでご注意ください。
Page Top